SMITH & NEPHEW PLC
About SMITH & NEPHEW PLC
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $13.0B
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $13.0B
- Dividend yield
- 3.18%
- Shares outstanding
- 428.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 16, 1999
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 22% below its 52-week high.
- Pays a dividend yielding about 3.18% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SMITH & NEPHEW PLC.
Write a review
News about SMITH & NEPHEW PLC
News & sentiment via Polygon.io
